Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies

The global expansion of COVID-19 and the mutations of severe acute respiratory syndrome coronavirus necessitate quick development of treatment and vaccination. Because the androgen-responsive serine protease TMPRSS2 is involved in cleaving the SARS-CoV-2 spike protein allowing the virus to enter the...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzain, Abdulrahim A., Elbadwi, Fatima A., Alsamani, Fatima O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806845/
https://www.ncbi.nlm.nih.gov/pubmed/35128036
http://dx.doi.org/10.1016/j.imu.2022.100870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806845/
https://www.ncbi.nlm.nih.gov/pubmed/35128036
http://dx.doi.org/10.1016/j.imu.2022.100870

Ejemplares similares